SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-24-087965
Filing Date
2024-08-12
Accepted
2024-08-09 21:34:29
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 tm2421169-2_424b.htm 424B3 7274516
2 GRAPHIC tb_pipeline-4c.jpg GRAPHIC 42665
3 GRAPHIC tb_incidence-4c.jpg GRAPHIC 86910
4 GRAPHIC tb_antigen-4clr.jpg GRAPHIC 140327
5 GRAPHIC tb_immune-4clr.jpg GRAPHIC 81337
6 GRAPHIC tb_treat-bw.jpg GRAPHIC 41428
7 GRAPHIC tb_antibodies-4clr.jpg GRAPHIC 76221
8 GRAPHIC sg_withum-4clr.jpg GRAPHIC 6782
9 GRAPHIC px_24irisspecialmeet01-bw.jpg GRAPHIC 451083
10 GRAPHIC px_24irisspecialmeet02-bw.jpg GRAPHIC 715667
  Complete submission text file 0001104659-24-087965.txt   9525499
Mailing Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623
Business Address 6 CENTERPOINTE DR. #625 LA PALMA CA 90623 213-273-5453
Iris Parent Holding Corp. (Filer) CIK: 0001971387 (see all company filings)

IRS No.: 000000000
Type: 424B3 | Act: 33 | File No.: 333-275409 | Film No.: 241194549
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)